FR2596649B1 - Procede de preparation de comprimes a effet entretenu pour usage oral, et comprimes ainsi obtenus - Google Patents

Procede de preparation de comprimes a effet entretenu pour usage oral, et comprimes ainsi obtenus

Info

Publication number
FR2596649B1
FR2596649B1 FR878703240A FR8703240A FR2596649B1 FR 2596649 B1 FR2596649 B1 FR 2596649B1 FR 878703240 A FR878703240 A FR 878703240A FR 8703240 A FR8703240 A FR 8703240A FR 2596649 B1 FR2596649 B1 FR 2596649B1
Authority
FR
France
Prior art keywords
tablets
preparation
oral use
maintained effect
maintained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR878703240A
Other languages
English (en)
Other versions
FR2596649A1 (fr
Inventor
Luciano Fontanelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Gentili SpA
Original Assignee
Istituto Gentili SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Gentili SpA filed Critical Istituto Gentili SpA
Publication of FR2596649A1 publication Critical patent/FR2596649A1/fr
Application granted granted Critical
Publication of FR2596649B1 publication Critical patent/FR2596649B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
FR878703240A 1986-03-11 1987-03-10 Procede de preparation de comprimes a effet entretenu pour usage oral, et comprimes ainsi obtenus Expired FR2596649B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19693/86A IT1204294B (it) 1986-03-11 1986-03-11 Metodo di fabbricazione di granulari atti a produzione di compresse rivestite,per uso orale,a rilascio controllato

Publications (2)

Publication Number Publication Date
FR2596649A1 FR2596649A1 (fr) 1987-10-09
FR2596649B1 true FR2596649B1 (fr) 1989-12-22

Family

ID=11160428

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878703240A Expired FR2596649B1 (fr) 1986-03-11 1987-03-10 Procede de preparation de comprimes a effet entretenu pour usage oral, et comprimes ainsi obtenus

Country Status (5)

Country Link
US (1) US4786506A (fr)
DE (1) DE3707571A1 (fr)
FR (1) FR2596649B1 (fr)
GB (1) GB2187643B (fr)
IT (1) IT1204294B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
DE3827214A1 (de) * 1988-08-11 1990-02-15 Roehm Gmbh Retardierte arzneiform und verfahren zu ihrer herstellung
IT1233163B (it) * 1989-03-01 1992-03-14 Zanchetta Aldo Procedimento di sferonizzazione e dispositivo per l'attuazione di detto procedimento
US5175003A (en) * 1990-04-06 1992-12-29 Biosytes Usa, Inc. Dual mechanism controlled release system for drug dosage forms
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
IT1270216B (it) * 1994-06-14 1997-04-29 Recordati Chem Pharm Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
EP1009387B1 (fr) 1997-07-02 2006-04-12 Euro-Celtique S.A. Formulations de tramadol stabilisees a liberation prolongee
US6337091B1 (en) 1997-10-27 2002-01-08 Temple University - Of The Commonwealth System Of Higher Education Matrix for controlled delivery of highly soluble pharmaceutical agents
US6274162B1 (en) 2000-01-14 2001-08-14 Bpsi Holdings, Inc. Elegant film coating system
CA2440641A1 (fr) * 2001-03-13 2002-09-19 Anand R. Baichwal Formes pharmaceutiques chronotherapeutiques contenant un glucocorticosteroide
US20050118267A1 (en) * 2003-09-19 2005-06-02 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
NZ545921A (en) * 2003-09-19 2009-09-25 Penwest Pharmaceuticals Co Delayed released dosage forms
CA2575988C (fr) * 2004-08-04 2014-02-18 Brookwood Pharmaceuticals, Inc. Procede de production de systemes d'administration, et systemes d'administration
CA2936746C (fr) 2014-10-31 2017-06-27 Purdue Pharma Methodes et compositions destinees au traitement du trouble de deficit d'attention
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT30380B (de) * 1906-09-26 1907-10-25 Siemens Ag Elektrische Kupplungsauswähleinrichtung für Eisenbahnsignale.
DE1467781A1 (de) * 1963-07-15 1968-12-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
US3400185A (en) * 1965-04-08 1968-09-03 Bristol Myers Co Agglomeration of smaller pharmaceutical particles into larger microspherules and enteic-coating thereof
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
US3487138A (en) * 1966-11-23 1969-12-30 Merck & Co Inc Process for preparing a delayed release medicinal tablet
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
US3692896A (en) * 1968-06-14 1972-09-19 Isumura Juntendo Co Ltd Process for the preparation of water-soluble tablets
US3608030A (en) * 1969-05-21 1971-09-21 Howard Tint Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations
US3629393A (en) * 1969-09-11 1971-12-21 Nikken Chemicals Co Ltd Release-sustaining-tablet
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
US3836618A (en) * 1971-12-23 1974-09-17 American Home Prod Process for the uniform distribution of a drug on a granulated base
DE2251249A1 (de) * 1972-10-19 1974-05-02 Hoechst Ag Verfahren zur herstellung von penicillin-verbindungen enthaltenden tabletten
US4113816A (en) * 1973-07-12 1978-09-12 Choay S.A. Process for the manufacture of layered tablets incorporating controlled-release microcapsules
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
US4088798A (en) * 1975-11-11 1978-05-09 Sandoz, Inc. Methods for the preparation of controlled gastric residence time medicament formulations
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
US4521402A (en) * 1983-01-03 1985-06-04 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of hydrazine
US4495177A (en) * 1983-01-17 1985-01-22 Shaklee Corporation Gel tableting agent
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
US4591496A (en) * 1984-01-16 1986-05-27 Massachusetts Institute Of Technology Process for making systems for the controlled release of macromolecules
HU191246B (en) * 1984-02-21 1987-01-28 Alkaloida Vegyeszeti Gyara,Hu Process for producing oral pharmaceutical compositions of retaed activity
DE3532692A1 (de) * 1985-09-13 1987-03-19 Boehringer Mannheim Gmbh Verfahren zum herstellen von tabletten aus pellets

Also Published As

Publication number Publication date
GB2187643A (en) 1987-09-16
US4786506A (en) 1988-11-22
IT1204294B (it) 1989-03-01
DE3707571A1 (de) 1987-09-17
GB8705608D0 (en) 1987-04-15
GB2187643B (en) 1990-02-14
IT8619693A0 (it) 1986-03-11
FR2596649A1 (fr) 1987-10-09

Similar Documents

Publication Publication Date Title
FR2596649B1 (fr) Procede de preparation de comprimes a effet entretenu pour usage oral, et comprimes ainsi obtenus
PT83849A (en) Process for the preparation of sulfomethylamide-containing polymers
MA21413A1 (fr) Nouveau procede de preparation d'alcoxy-guanine
DE3569375D1 (en) Process for the preparation of 1,2-benzisothiazolones
PT83913A (en) Process for the production of block copolymer of propylene
FR2583758B1 (fr) Procede pour la preparation de solutions diluees de polymere
BE891557A (fr) Procede de preparation de comprimes analgesiques, directement compressibles, d'acetaminophene renfermant de la carboxyme-thylcellulose sodique et nouveaux produits ainsi obtenus
PT82950A (en) Process for the preparation of antimicrobian isothiazolone solutions
ZA879328B (en) Azumolene dosage form
FR2647346B1 (fr) Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament
DE3265210D1 (en) Novel compounds with antiinflammatory and analgesic activity, process for the preparation thereof and pharmaceutical compositions therefrom
PT83197A (en) Process for the preparation of 7-oxo-4-thia-1-azabicyclo <3,2,0>hept-2-ene derivatives
FR2610924B1 (fr) Procede de preparation d'hydroxybiphenyles
FR2634765B1 (fr) Procede pour la preparation de levo- et de dextro-dropropizine
GR861895B (en) Process for the preparation of 3,7-disubstituted-3-cephem compounds
FR2588861B1 (fr) Procede pour la preparation de para-quinones
ZA865560B (en) 3-(3-iodopropargyloxy)-propionitrile,a process for its preparation and its use
FR2575749B1 (fr) Procede pour la preparation de composes de type pyrone-3-carboxamide
EP0198795A3 (en) Process for the preparation of 1,4-diaminoanthraquinones
RO91889A2 (fr) Procede pour la preparation de l'azobisisobutyronitryle
FR2595353B1 (fr) Procede de preparation d'encainide
EP0206293A3 (en) Process for the preparation of 3,5-dichloro-2-pyridone
FR2590582B1 (fr) Procede pour la preparation de copolymeres
FR2588557B1 (fr) Procede de preparation d'arylaminoaluminium
FR2603582B1 (fr) Procede de preparation d'arylacetonitriles

Legal Events

Date Code Title Description
ST Notification of lapse